logo
Share SHARE
FONT-SIZE Plus   Neg

Isotechnika Pharma Obtains Notice Of ILJIN's Request For Arbitration

Isotechnika Pharma Inc. (ISA.TO) announced that it has received notification that ILJIN Life Science Co., Ltd. has submitted a request for arbitration relating to Isotechnika's termination of their Development, Distribution and License Agreement or "DDL".

"We are confident that our termination of the original DDL is valid, and are prepared for arbitration proceedings. We plan on continuing to engage companies, including ILJIN, who have expressed interest in working with us to advance our lead program," said Robert Foster, Isotechnika's CEO.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
A federal judge has dismissed a lawsuit that accused Starbucks (SBUX) of cheating customers by "under-filling" its cold beverages. The lawsuit alleged that Starbucks is deceiving its customers by serving iced drinks with too much ice cubes and less coffee "than advertised." "If children have figured... Apparel retailer Guess? Inc. (GES) on Wednesday reported an increase in profit for the second quarter, despite lower-than-expected revenues reflecting a one-time gain. Earnings for the quarter easily trumped Wall Street estimates, sending the company's stock up over 14 percent in extended hours. Guess'... HP Inc. (HPQ) on Wednesday reported a drop in profit for the third quarter hurt largely by a 4 percent drop in revenues as the company continues to struggle with weak demand for printers. Shares of the computer and printer maker slipped 5 percent in extended session after it detailed a weak fourth quarter...
comments powered by Disqus
Follow RTT